Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/ekmpCfbwocfbunylXawR

February 14, 2013News for medical technology professionals

  Top Story 
10 ways to inspire creativity in your staff.
Fostering creative business practices isn't as hard as it seems and can lead to smart solutions. Use these ten techniques to help inspire and encourage creativity in your staff. Read the article and learn 10 ways to get the creative juices flowing.

  Business & Market Trends 
 
  • AB Sciex prepares to make inroads in IVD market
    AB Sciex hopes to expand into the in vitro diagnostics market with its AB Sciex API 3200MD and 3200MD QTRAP LC/MS/MS devices, designed to analyze compounds in human specimens. The new product line is "in response to the demand in clinical settings for mass spectrometers as medical devices that meet regulatory requirements," company President Rainer Blair said. Genetic Engineering & Biotechnology News (2/13) LinkedInFacebookTwitterEmail this Story
  • Nanosphere reports Q4 revenues, management shuffle
    Nanosphere announced that it doubled its annual revenue last year and reported revenue of $1.6 million during the fourth quarter, driven in large part by U.S. sales of its testing products for gram-positive respiratory and blood stream infections. The firm also announced the appointment of Michael McGarrity as its new president and CEO, and Sheli Rosenberg as its new board chairwoman, among other management changes. GenomeWeb Daily News (free registration) (2/14) LinkedInFacebookTwitterEmail this Story
SHRM Exec Study: Impact of Absence
Read the compelling results of this 2014 survey conducted by SHRM and Kronos® that demonstrate how a clearly defined strategy to monitor and manage absence, with proper training and automation, can help control costs associated with absences and improve your bottom line. Click here to learn more.

  International Developments 
 
  • Wis. medical injection molder plans facility expansion in Finland
    Phillips-Medisize, a Hudson, Wis.-based medical injection molder, plans to set up a 60,000-square-foot facility in Kontiolahti, Finland. The expansion plan is part of the company's effort to increase its medical molding capabilities to meet the rising demand for drug-delivery systems manufactured in that country, President and CEO Matt Jennings said. PlasticsNews.com (2/13) LinkedInFacebookTwitterEmail this Story
Combating Identity Theft in a Mobile, Social World
Mobile connectivity threats extend from consumers to the business environment. But who is really responsible for securing sensitive information? Smart business leaders are becoming proactive on the matter. Learn how to get protected in this white paper. Download the white paper now.

  Industry Insight 
 

Whitepaper: SDN: How do you get there from here?
Are the growing data needs of mobile, cloud, big data and social threatening today's enterprise networks? Scalable processes, a phased integration approach and the appetite to optimize over time are key components of a modern network. It's how agile organizations prepare for the data needs of tomorrow.
Explore the whitepaper to start down the path toward SDN.

  Science & Health 
  • Studies aim to test expanded uses for transcatheter aortic valve
    The Society of Thoracic Surgeons and the American College of Cardiology recently have received investigational device exemption approval from the FDA to conduct a clinical study evaluating the use of Edwards Lifesciences' Sapien device in patients who are deemed not eligible for aortic valve surgery. The groups are now pursuing FDA approval for two more studies in hopes of expanding the uses of transcatheter aortic valve replacement. Forbes (2/12) LinkedInFacebookTwitterEmail this Story
  Emerging Technologies 
  • Bio-scaffold may allow for regrowth of broken bones
    Researchers from the U.K. used a method called "solvent blending" to create a degradable, plastic bio-scaffold that can be inserted into broken bones to induce them to regrow. Stem cells from the bone marrow are carried by the blood through the scaffold, where they can attach and generate new bone tissue. The researchers are preparing for human trials. The findings were published in the journal Advanced Functional Materials. Medical News Today (2/11) LinkedInFacebookTwitterEmail this Story
  Government & Regulatory 
  • FDA issues notice to Hospira over medical device issues
    Hospira said it has received a notice from the FDA over certain quality concerns involving its medical devices. CEO F. Michael Ball said that while inspectors noted progress had been made, "there is still a lot of work to be done within our device operations." Reuters (2/13) LinkedInFacebookTwitterEmail this Story
AdvaMed News 
Learn more about AdvaMed ->About AdvaMed | Join | Courses | Events | Newsroom

 
Position TitleCompany NameLocation
Neurovascular Intervention Marketing ManagerAsahi InteccSanta Ana, CA
Biostatistician - Post Market Surveillance Johnson & JohnsonRaynham, MA
Director of ManufacturingMBio Diagnostics, Inc.Boulder, CO
Director of Global Infrastructure - 002196Edwards LifesciencesIrvine, CA
DIR OPERATIONS, Milpitas Site - 130000007RAbbott San Jose, CA
Regional Service Manager PhilipsHartford, CT
Engineer, Process DevelopmentArthroCare CorporationIrvine, CA
Sr. QA Manager - Quality Systems (Santa Barbara)AllerganSanta Barbara, CA
Product Support Specialist IVArthroCare CorporationAustin, TX
Legal Counsel IIMedtronic, Inc.Minneapolis, MN or Washington, DC, United States
Click here to view more job listings.

  SmartQuote 
Mistakes are part of the dues that one pays for a full life."
--Sophia Loren,
Italian actress


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Account Director:  Meryl Harold (202) 407-7828
Job Board:  Jackie Basso (202) 407-7871
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AdvaMed SmartBrief Issues:   Lead Editor:  Lisa Gough
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information